U.S. RESEARCH ROUNDUP-BXP, Medpace Holdings, Starbucks

Reuters10-23

Oct 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including BXP, Medpace Holdings and Starbucks, on Wednesday.

HIGHLIGHTS

* BXP Inc : Piper Sandler raises to overweight from neutral

* $Danaher Corp(DHR-W)$ : TD Cowen raises target price to $315 from $310

* Medpace Holdings Inc : Jefferies cuts target price to $305 from $345

* Starbucks : Stifel cuts target price to $105 from $110

* Wintrust Financial Corp : Truist Securities raises PT to $127 from $123

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Banc of California Inc : D.A. Davidson raises target price to $19 from $16.50

* BXP Inc : Piper Sandler raises target price to $105 from $78

* BXP Inc : Piper Sandler raises to overweight from neutral

* Cadence Bank : Truist Securities raises target price to $38 from $37

* Costar Group Inc : JP Morgan cuts target price to $99 from $108

* Danaher Corp : Leerink Partners cuts target price to $275 from $280

* Danaher Corp : TD Cowen raises target price to $315 from $310

* East West Bancorp Inc : Truist Securities raises target price to $101 from $93

* Enova International Inc : BTIG raises target price to $110 from $90

* Enova International Inc : Jefferies raises target price to $110 from $95

* Enova International Inc : TD Cowen raises target price to $96 from $$85

* Enphase Energy Inc : JP Morgan cuts target price to $120 from $130

* Enphase Energy Inc : Piper Sandler cuts target price to $85 from $105

* Fiserv Inc : JP Morgan raises target price to $227 from $199

* Genuine Parts Co : Jefferies cuts target price to $125 from $153

* GM : Daiwa Capital Markets raises target price to $53 from $50

* Hershey : Piper Sandler cuts target price to $165 from $179

* Incyte : JP Morgan raises target price to $65 from $61

* Independent Bank Group Inc : Truist Securities cuts PT to $63 from $66

* Iqvia Holdings Inc : JP Morgan cuts target price to $279 from $288

* Italy'S Prysmian : HSBC raises target price to EUR 75 from EUR 70

* Lockheed Martin Corp : TD Cowen raises target price to $610 from $560

* Madrigal Pharmaceuticals Inc : Oppenheimer cuts target price to $350 from $375

* Medpace Holdings Inc : Jefferies cuts target price to $305 from $345

* Medpace Holdings Inc : TD Cowen cuts target price to $372 from $413

* Mondelez : Piper Sandler cuts target price to $74 from $76

* Patrick Industries Inc : Keybanc raises target price to $150 from $135

* Peoples Bancorp Inc : Piper Sandler cuts target price to $36 from $39

* Philip Morris : JP Morgan raises target price to $145 from $125

* Polaris Inc : Keybanc cuts target price to $80 from $90

* Pultegroup Inc : BTIG raises target price to $156 from $139

* Robert Half Inc : JP Morgan cuts target price to $69 from $70

* Sherwin-Williams Co : JP Morgan raises target price to $370 from $360

* Schlumberger : HSBC cuts target price to $52 from $71

* Starbucks : Stifel cuts target price to $105 from $110

* Tradeweb Markets Inc : JP Morgan raises target price to $146 from $119

* Uipath Inc : JP Morgan cuts target price to $17 from $19

* $Vornado Realty Trust(VNO-N)$ : Piper Sandler raises target price to $44 from $30

* Wintrust Financial Corp : Truist Securities raises PT to $127 from $123

* Zions Bancorporation Na : Truist Securities raises target price to $57 from $52

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment